About apyx medical - APYX
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
APYX At a Glance
Apyx Medical Corp.
5115 Ulmerton Road
Clearwater, Florida 33760-4004
| Phone | 1-727-384-2323 | Revenue | 52.84M | |
| Industry | Medical Specialties | Net Income | -11,211,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 9.858% | |
| Fiscal Year-end | 12 / 2026 | Employees | 205 | |
| View SEC Filings |
APYX Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.722 |
| Price to Book Ratio | 10.059 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -26.20 |
| Enterprise Value to Sales | 2.871 |
| Total Debt to Enterprise Value | 0.259 |
APYX Efficiency
| Revenue/Employee | 257,775.61 |
| Income Per Employee | -54,687.805 |
| Receivables Turnover | 3.15 |
| Total Asset Turnover | 0.803 |
APYX Liquidity
| Current Ratio | 4.998 |
| Quick Ratio | 4.262 |
| Cash Ratio | 2.713 |
APYX Profitability
| Gross Margin | 36.017 |
| Operating Margin | -12.198 |
| Pretax Margin | -20.504 |
| Net Margin | -21.215 |
| Return on Assets | -17.027 |
| Return on Equity | -77.99 |
| Return on Total Capital | -20.807 |
| Return on Invested Capital | -21.139 |
APYX Capital Structure
| Total Debt to Total Equity | 270.564 |
| Total Debt to Total Capital | 73.014 |
| Total Debt to Total Assets | 58.857 |
| Long-Term Debt to Equity | 267.62 |
| Long-Term Debt to Total Capital | 72.22 |